An FDA advisory panel votes 20-2 in favor of recommending Vivus (VVUS) weight-loss drug Qnexa....

|By:, SA News Editor

An FDA advisory panel votes 20-2 in favor of recommending Vivus (VVUS) weight-loss drug Qnexa. Shares still halted. (earlier)